In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 1, 2011, Pages 112-118

  Cha, Jeong Ok ^a,b   Park, Yong Keun ^b   Lee, Yeong Seon ^a   Chung, Gyung Tae ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b Korea University   (South Korea)

Author keywords

Bactericidal activity; MBC; MIC; MRSA

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPLANKTON; BACTERIOSTASIS; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BIOFILM; CELL CLONE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM BIOFILM ERADICATION CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOUTH KOREA;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; REPUBLIC OF KOREA; STAPHYLOCOCCAL INFECTIONS;

EID: 79955033377     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.11.018     Document Type: Article

References (35)

1. Ando E., Monden K., Mitsuhata R., Kariyama R., Kumon H. Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama 2004, 58:207-214.
2. Antunes A.L., Trentin D.S., Bonfanti J.W., Pinto C.C., Perez L.R., Macedo A.J., Barth A.L. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci. APMIS 2010, 118:873-877.
3. Aslam S., Trautner B.W., Ramanathan V., Darouiche R.O. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 2007, 51:1556-1558.
4. Bae I.G., Kim J.S., Kim S., Heo S.T., Chang C., Lee E.Y. Genetic correlation of community-associated methicillin-resistant Staphylococcus aureus strains from carriers and from patients with clinical infection in one region of Korea. J Kor Med Sci 2010, 25:197-202.
5. Binswanger I.A., Kral A.H., Bluthenthal R.N., Rybold D.J., Edlin B.R. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000, 30:579-581.
6. Coelho L.R., Souza R.R., Ferreira F.A., Guimaraes M.A., Ferreira-Carvalho B.T., Sa Fiqueiredo A.M. agr RNAIII divergently regulates glucose-induced biofilm formation in clinical isolates of Staphylococcus aureus. Microbiol 2008, 154:3480-3490.
7. Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., Beachey E.H. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for adherence of staphylococci to medical devices. J Clin Microbiol 1985, 22:996-1006.
8. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2006, CLSI, (Approved standard CLSI M7-A7). 7th ed.
9. Donlan R.M. Biofilms and device-associated infections. Emerg Infect Dis 2001, 7:277-281.
10. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
11. Gonzalez B.E., Rueda A.M., Shelburne S.A., Musher D.M., Hamill R.J., Hulten K.G. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006, 27:1051-1056.
12. Götz F. Staphylococcus and biofilms. Mol Microbiol 2002, 43:1367-1378.
13. Huang Y.H., Tseng S.P., Hu J.M., Tsai J.C., Hsueh P.R., Teng L.J. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect 2007, 13:717-724.
14. Iwatsuki K., Yamasaki O., Morizane S., Oono T. Staphylococcal cutaneous infections: Invasion, evasion and aggression. J Dermatol Sci 2006, 42:203-214.
15. Kwon A.S., Park G.C., Ryu S.Y., Lim D.H., Lim D.Y., Choi C.H., Park Y., Lim Y. Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. Int J Antimicrob Agents 2008, 32:68-72.
16. Labthavikul P., Petersen P.J., Bradford P.A. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother 2003, 47:3967-3969.
17. Ladhani S., Joannou C.L., Lochrie D.P., Evans R.W., Poston S.M. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scaled-skin syndrome. Clin Microbiol Rev 1999, 12:224-242.
18. Lauderdale K.J., Malone C.L., Boles B.R., Morcuende J., Horswill A.R. Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J Orthop Res 2010, 28:55-61.
19. Ma S.H., Lee Y.S., Lee S.H., Kim H.K., Jin J.S., Shin E.K., Lee J.C. Methicillin-resistant Staphylococcus aureus clones with distinct clinical and microbiological features in Korean community. J Med Microbiol 2007, 56:866-868.
20. Miller L.G., Diep B.A. Clinical practice: colonization, formites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008, 46:752-760.
21. Moskowitz S.M., Foster J.M., Emerson J., Burns J.L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004, 42:1915-1922.
22. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., Johnson S.K., Vandenesch F., Fridkin S., O'Boyle C., Danila R.N., Lynfield R. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
23. Olivera D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:2155-2161.
24. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008, 322:207-228.
25. Paintsil E. Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management. Curr Opin Pediatr 2007, 19:75-82.
26. Park C., Lee D.G., Kim S.W., Choi S.M., Park S.H., Chun H.S., Choi J.H., Yoo J.H., Shin W.S., Kang J.H., Kim J.H., Lee S.Y., Kim S.M., Pyun B.Y. Predominance of community-associated methicillin-resistant Staphylococcus aureus strains carrying staphylococcal chromosome cassette mec type IVA in South Korea. J Clin Microbiol 2007, 45:4021-4026.
27. Park S.H., Park C., Yoo J.H., Choi S.M., Choi J.H., Shin H.H., Lee D.G., Lee S., Kim J., Choi S.E., Kwon Y.M., Shin W.S. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infect Control Hosp Epidemiol 2009, 30:146-155.
28. Presterl E., Hajdu S., Lassnigg A.M., Hirschl A., Holinka J., Graninger W. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2009, 53:3205-3210.
29. Raad I., Hanna H., Jiang Y., Dvorak T., Reitzel R., Chaiban G., Sherertz R., Hachem R. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007, 51:1656-1660.
30. Sader H.S., Fritsche T.R., Jones R.N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob Agents Chemother 2006, 50:2330-2336.
31. Saginur R., Stdenis M., Ferris W., Aaron S.D., Chan F., Lee C., Ramotar K. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006, 50:55-61.
32. Smith K., Perez A., Ramage G., Gemmell C.G., Lang S. Comparision of biofilm-associated cell survival following in vitro exposure of methicillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009, 33:374-378.
33. Spoering A.L., Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001, 183:6746-6751.
34. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Disease 2003, 9:978-984.
35. Zhang K., McClure J.A., Elsayed S., Louie T., Conly J.M. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005, 43:5026-5033.